Lexicon Pharmaceuticals
LXRX
#7387
Rank
โ‚น41.46 B
Marketcap
โ‚น114.07
Share price
7.76%
Change (1 day)
80.53%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.34. In 2024 the company made an earnings per share (EPS) of -โ‚น58.40 an increase over its 2023 EPS that were of -โ‚น73.00.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.92%
2024-โ‚น58.40-20%
2023-โ‚น73.0031.15%
2022-โ‚น55.67-0%
2021-โ‚น55.6710.91%
2020-โ‚น50.19-145.08%
2019โ‚น111.33-206.09%
2018-โ‚น104.94-5.74%
2017-โ‚น111.33-10.95%
2016-โ‚น125.022640%
2015-โ‚น4.56-96.34%
2014-โ‚น124.53-2.53%
2013-โ‚น127.76-9.09%
2012-โ‚น140.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,582-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น407.91-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,964-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น542.05 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น218.10-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น45.63 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น68.44 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น248.21-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,000 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA